191 related articles for article (PubMed ID: 38459207)
1. Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases.
Sarkar S; Roy D; Chatterjee B; Ghosh R
Metabolomics; 2024 Mar; 20(2):37. PubMed ID: 38459207
[TBL] [Abstract][Full Text] [Related]
2. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.
Zhao YY; Cheng XL; Lin RC
Int Rev Cell Mol Biol; 2014; 313():1-26. PubMed ID: 25376488
[TBL] [Abstract][Full Text] [Related]
3. Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease.
Zhao YY; Miao H; Cheng XL; Wei F
Chem Biol Interact; 2015 Oct; 240():220-38. PubMed ID: 26358168
[TBL] [Abstract][Full Text] [Related]
4. Lipidomics applications for disease biomarker discovery in mammal models.
Zhao YY; Cheng XL; Lin RC; Wei F
Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902
[TBL] [Abstract][Full Text] [Related]
5. Novel advances in shotgun lipidomics for biology and medicine.
Wang M; Wang C; Han RH; Han X
Prog Lipid Res; 2016 Jan; 61():83-108. PubMed ID: 26703190
[TBL] [Abstract][Full Text] [Related]
6. Surface analysis of lipids by mass spectrometry: more than just imaging.
Ellis SR; Brown SH; In Het Panhuis M; Blanksby SJ; Mitchell TW
Prog Lipid Res; 2013 Oct; 52(4):329-53. PubMed ID: 23623802
[TBL] [Abstract][Full Text] [Related]
7. The use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: A review.
Schubert KO; Weiland F; Baune BT; Hoffmann P
Proteomics; 2016 Jun; 16(11-12):1747-58. PubMed ID: 27303929
[TBL] [Abstract][Full Text] [Related]
8. Lipidomics of Bioactive Lipids in Alzheimer's and Parkinson's Diseases: Where Are We?
Chiurchiù V; Tiberi M; Matteocci A; Fazio F; Siffeti H; Saracini S; Mercuri NB; Sancesario G
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682914
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in lipidomics for disease research.
Yang L; Li M; Shan Y; Shen S; Bai Y; Liu H
J Sep Sci; 2016 Jan; 39(1):38-50. PubMed ID: 26394722
[TBL] [Abstract][Full Text] [Related]
10. Lipids and lipidomics in brain injury and diseases.
Adibhatla RM; Hatcher JF; Dempsey RJ
AAPS J; 2006 May; 8(2):E314-21. PubMed ID: 16796382
[TBL] [Abstract][Full Text] [Related]
11. Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson's disease.
Gątarek P; Kałużna-Czaplińska J
Expert Rev Proteomics; 2024; 21(1-3):13-25. PubMed ID: 38346207
[TBL] [Abstract][Full Text] [Related]
12. Lipidomics: quest for molecular lipid biomarkers in cardiovascular disease.
Hinterwirth H; Stegemann C; Mayr M
Circ Cardiovasc Genet; 2014 Dec; 7(6):941-54. PubMed ID: 25516624
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of MALDI imaging technologies in cancer and neurodegenerative diseases.
Ucal Y; Durer ZA; Atak H; Kadioglu E; Sahin B; Coskun A; Baykal AT; Ozpinar A
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):795-816. PubMed ID: 28087424
[TBL] [Abstract][Full Text] [Related]
14. Brain lipidomics as a rising field in neurodegenerative contexts: Perspectives with Machine Learning approaches.
Castellanos DB; Martín-Jiménez CA; Rojas-Rodríguez F; Barreto GE; González J
Front Neuroendocrinol; 2021 Apr; 61():100899. PubMed ID: 33450200
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in lipidomics: Analytical and clinical perspectives.
Sethi S; Brietzke E
Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():8-16. PubMed ID: 28039059
[TBL] [Abstract][Full Text] [Related]
16. MALDI-MSI-LC-MS/MS Workflow for Single-Section Single Step Combined Proteomics and Quantitative Lipidomics.
Hendriks TFE; Krestensen KK; Mohren R; Vandenbosch M; De Vleeschouwer S; Heeren RMA; Cuypers E
Anal Chem; 2024 Mar; 96(10):4266-4274. PubMed ID: 38469638
[TBL] [Abstract][Full Text] [Related]
17. Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging.
Michno W; Wehrli PM; Koutarapu S; Marsching C; Minta K; Ge J; Meyer SW; Zetterberg H; Blennow K; Henkel C; Oetjen J; Hopf C; Hanrieder J
J Neurochem; 2022 Feb; 160(4):482-498. PubMed ID: 34882796
[TBL] [Abstract][Full Text] [Related]
18. Spatial lipidomics and metabolomics of multicellular tumor spheroids using MALDI-2 and trapped ion mobility imaging.
Chen J; Xie P; Dai Q; Wu P; He Y; Lin Z; Cai Z
Talanta; 2023 Dec; 265():124795. PubMed ID: 37364385
[TBL] [Abstract][Full Text] [Related]
19. Mass Spectrometry Imaging for Single-Cell or Subcellular Lipidomics: A Review of Recent Advancements and Future Development.
Li D; Ouyang Z; Ma X
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985684
[TBL] [Abstract][Full Text] [Related]
20. From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology.
Toader C; Dobrin N; Brehar FM; Popa C; Covache-Busuioc RA; Glavan LA; Costin HP; Bratu BG; Corlatescu AD; Popa AA; Ciurea AV
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
